# Mendelian randomization and transcriptomic analysis identify HE4 as a potential biomarker for chronic obstructive pulmonary disease
1. MR.R for mendelian randomization analysis.
2. DE.R for transcriptomic and receiver operating characteristic (ROC) analysis.
